Dr. Glenn Currier, MD

NPI: 1194753012
Total Payments
$10,833
2024 Payments
$43.12
Companies
3
Transactions
10
Medicare Patients
311
Medicare Billing
$78,250

Payment Breakdown by Category

Consulting$6,000 (55.4%)
Research$2,500 (23.1%)
Travel$1,980 (18.3%)
Food & Beverage$352.20 (3.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $6,000 2 55.4%
Unspecified $2,500 1 23.1%
Travel and Lodging $1,980 3 18.3%
Food and Beverage $352.20 4 3.3%

Payments by Type

General
$8,333
9 transactions
Research
$2,500
1 transactions

Top Paying Companies

Company Total Records Latest Year
Janssen Pharmaceuticals, Inc $8,289 8 $0 (2019)
Avanir Pharmaceuticals, Inc. $2,500 1 $0 (2020)
ABIOMED $43.12 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $43.12 1 ABIOMED ($43.12)
2020 $2,500 1 Avanir Pharmaceuticals, Inc. ($2,500)
2019 $8,289 8 Janssen Pharmaceuticals, Inc ($8,289)

All Payment Transactions

10 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
11/19/2024 ABIOMED Impella (Device) Food and Beverage Cash or cash equivalent $43.12 General
Category: Cardiology/Vascular Diseases
08/20/2020 Avanir Pharmaceuticals, Inc. Cash or cash equivalent $2,500.00 Research
Study: AVA1407 Observational Study in IED
12/27/2019 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Consulting Fee Cash or cash equivalent $3,000.00 General
Category: Neuroscience
12/27/2019 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Consulting Fee Cash or cash equivalent $3,000.00 General
Category: Neuroscience
12/27/2019 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Travel and Lodging In-kind items and services $964.56 General
Category: Neuroscience
12/27/2019 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Travel and Lodging In-kind items and services $926.07 General
Category: Neuroscience
12/27/2019 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $171.72 General
Category: Neuroscience
12/27/2019 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Travel and Lodging Cash or cash equivalent $89.72 General
Category: Neuroscience
12/27/2019 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $87.26 General
Category: Neuroscience
12/27/2019 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage Cash or cash equivalent $50.10 General
Category: Neuroscience

Research Studies & Clinical Trials

Study Name Company Amount Records
AVA1407 Observational Study in IED Avanir Pharmaceuticals, Inc. $2,500 1

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 101 208 $77,415 $18,433
2022 3 80 233 $91,214 $22,127
2021 2 68 217 $76,276 $21,514
2020 2 62 209 $64,654 $16,177
Total Patients
311
Total Services
867
Medicare Billing
$78,250
Procedure Codes
9

All Medicare Procedures & Services

9 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 81 187 $71,682 $17,217 24.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 20 21 $5,733 $1,217 21.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 51 201 $77,699 $19,253 24.8%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 12 12 $8,043 $1,777 22.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 17 20 $5,472 $1,097 20.1%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 52 194 $70,382 $19,956 28.4%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 16 23 $5,894 $1,558 26.4%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 44 175 $57,139 $14,355 25.1%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 18 34 $7,515 $1,821 24.2%

About Dr. Glenn Currier, MD

Dr. Glenn Currier, MD is a Psychiatry healthcare provider based in Portland, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194753012.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Glenn Currier, MD has received a total of $10,833 in payments from pharmaceutical and medical device companies, with $43.12 received in 2024. These payments were reported across 10 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($6,000).

As a Medicare-enrolled provider, Currier has provided services to 311 Medicare beneficiaries, totaling 867 services with total Medicare billing of $78,250. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.

Practice Information

  • Specialty Psychiatry
  • Other Specialties Psychiatry, Psychiatry
  • Location Portland, ME
  • Active Since 06/29/2006
  • Last Updated 07/21/2025
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • NPI Number 1194753012

Products in Payments

  • SPRAVATO (Drug) $8,289
  • Impella (Device) $43.12

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Portland